A Phase 3 Double-blind Study to Evaluate the Efficacy and Safety of Dexlansoprazole (30 mg QD) Compared to Placebo on Heartburn Relief in Subjects With Symptomatic Nonerosive Gastroesophageal Reflux Disease (GERD)
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007406/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the efficacy and safety of dexlansoprazole compared
to placebo in relief of daytime and nighttime heartburn over 4 weeks in Chinese participants
with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).
提供机构：
Vivli
创建时间：
2021-09-22
